3 February 2026CompletedHealthcare
Erigen to acquire Tempest Therapeutics, Inc.
Erigen and Tempest Therapeutics, Inc. entered the Exit Mode archive.
- Buyer
- Erigen
- Target
- Tempest Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
